Irene Kim, MD
Surgery · West Hollywood, CANPI 1932390390
Payments from drug & device makers
Across 89 payments — averaging $528.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$18K
- Johnson & Johnson$10K
- Transmedics, Inc.$8K
- Intuitive Surgical$5K
- Invivyd Inc$3K
- Xvivo Perfusion Inc.$1K
- plus $2K from 10 others
What the payments were for
- Consulting fees$28,90861%
- Travel & lodging$12,55327%
- Food & beverage$4,0129%
- Education$1,6053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 7 | $17,880 |
| Johnson & Johnson(3 entities) | 12 | $10,280 |
| Transmedics, Inc. | 5 | $7,606 |
| Intuitive Surgical | 35 | $4,970 |
| Invivyd Inc | 1 | $2,625 |
| Xvivo Perfusion Inc. | 5 | $1,418 |
| Medical Device Business Services, Inc. | 7 | $913 |
| Medtronic | 3 | $233 |
| Paragonix Technologies, Inc. | 1 | $197 |
| Boston Scientific | 2 | $185 |
| Veloxis Pharmaceuticals, Inc. | 2 | $180 |
| Acera Surgical, Inc. | 1 | $169 |
| Stryker | 1 | $156 |
| Novo Nordisk | 5 | $121 |
| AbbVie | 1 | $113 |
| Tactile Systems Technology Inc | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THYMOGLOBULIN$17,793
- ORGAN CARE SYSTEM$7,606
- PEMGARDA$2,625
- Da Vinci Surgical System$2,590
- DAVINCI XI$1,500
- XVIVO Perfusion System (XPS)$1,308
- SherpaPak$197
- LIVERguard$197
- LUNGguard$197
- BaroGuard$197
- PancreasPak$197
- Restrata Wound Matrix$169
- N/A$156
- Signia$143
- Envarsus$130
- TheraSphere Y90 Glass Microspheres 10 GBq$107
How this compares
$47,078 in reported general payments places this provider in the 90th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ursodiol | 38 | $2,825 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 20 | $1,288 |
| Acyclovir | 48 | $902 |
| Nifedipine ErNifedipine | 11 | $191 |
| Tamsulosin Hcl | 19 | $104 |
| Pantoprazole Sodium | 18 | $69 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 37 | $65 |
| Carvedilol | 31 | $51 |
Paid to pharmacies, not to this prescriber.
Other surgery in West Hollywood
- Daniel ShouhedWest Hollywood$214K
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
- Kenneth DeckLaguna Hills$2.4M
- Daniel RiskinSan Jose$2.2M
- Michael DemeureNewport Beach$1.7M
- Rock LiuHayward$1.6M
- David LouriePasadena$1.4M
- Andrea PakulaThousand Oaks$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.